Markets
ZeroStack Corp. (ZSTK)
ZSTKNASDAQ-CMOther Pharmaceuticals
$2.53
0.0000 (0.00%) today
Regular session, Nov 10, 4:00 PM ET
-5.95% 1D
- Market cap
- $56.73m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $2.60 to $2.60
- 52-week range
- $1.32 to $15.04
- Average volume
- 60.5k
- Previous close
- $2.53
Earnings
Next report
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $9.75m | $9.35m | $7.27m | $13.66m |
| Gross profit | $335.0k | $160.0k | $3.15m | $1.62m |
| Operating income | -$2.28m | -$149.24m | -$62.65m | -$24.23m |
| Net income | -$6.66m | -$109.90m | -$36.66m | -$24.61m |
Last four quarters: revenue $40.03m, margin -444.2%, free cash flow –
News
6 latest- Flora Growth Corp. Enters Agreement to Sell Phatebo GmbH for €2,150,000Fintel · 1 day ago
- Tuesday 7/21 Insider Buying Report: ZSTKBNK Invest · Jul 21, 2026
- Flora Growth Corp. (FLGC) Reports Q3 Loss, Misses Revenue EstimatesZacks · Nov 5, 2025
- Zimmer Biomet (ZBH) Q3 Earnings Surpass EstimatesZacks · Nov 5, 2025
- Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue EstimatesZacks · Aug 1, 2025
- FLORA GROWTH Earnings Results: $FLGC Reports Quarterly EarningsQuiver Quantitative · May 13, 2025
The company
ZeroStack Corp. is the first NASDAQ-listed asset management company focused on providing exposure to decentralized AI. The Company also operates a global pharmaceutical distribution business through its wholly owned subsidiary, Phatebo GmbH .
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- zerostack.ai
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.